Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.8.0.1
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2016
Nov. 14, 2016
Document and Entity Information [Abstract]    
Entity Registrant Name Immudyne, Inc.  
Entity Central Index Key 0000948320  
Amendment Flag true  
Amendment Description

This Amendment No. 1 on Form 10-Q/A (this “Form 10-Q/A”) to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2016, filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 14, 2016 (the “Original Filing”), is being filed in its entirety for the purpose of restating our unaudited condensed financial statements as of and for the three months ended September 30, 2016 and the corresponding financial data. The restatement is the result of an error in the accounting for the classification of marketing and advertising expenses.  As such the Company is restating its financial statements to reclass any marketing and advertising from the cost of goods sold account to marketing expenses part of operating expenses. These reclassifications have no impact on previously reported net income.

 

No changes, other than those that followed logically from the changes described above, have been made to the Original Filing. None of the other information included in the Original Filing has been updated. For current information regarding Immudyne, Inc., you should refer to the more recent filings made on EDGAR by the Company.

 

In addition, this Form 10-Q/A contains new certifications by our Principal Executive and Financial Officer, filed as exhibits hereto.

 
Current Fiscal Year End Date --12-31  
Document Type 10-Q/A  
Document Period End Date Sep. 30, 2016  
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q3  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   34,760,375